Income Statement Balance Sheet Cash Flow Statement
Annual Financials for GenVec Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 13.86M 16.47M 17.74M 9.35M 3.68M
Cost of Goods Sold (COGS) incl. D&A - 238,000 - - -
COGS excluding D&A - 0 - - -
Depreciation & Amortization Expense 1.06M 238,000 234,000 242,000 174,000
Depreciation 1.06M 238,000 234,000 242,000 174,000
Amortization of Intangibles - 0 0 0 0
Gross Income - 16.23M - - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 30.81M 28.47M 24.99M 23.21M 13.8M
Research & Development 24.69M 20.94M 17.42M 14.35M 5.49M
Other SG&A 6.12M 7.53M 7.58M 8.86M 8.31M
Other Operating Expense 0 0 0 0 0
Unusual Expense 7,000 251,000 (3,000) 0 -
EBIT after Unusual Expense (7,000) (251,000) 3,000 0 -
Non Operating Income/Expense (254,000) 213,000 1,000 0 0
Non-Operating Interest Income 38,000 4,000 37,000 42,000 275,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 128,000 0 0 0 0
Gross Interest Expense 128,000 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (18.36M) (12.27M) (7.44M) (14.06M) (10.02M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (18.36M) (12.27M) (7.44M) (14.06M) (10.02M)
Minority Interest Expense 0 0 0 0 0
Net Income (18.36M) (12.27M) (7.44M) (14.06M) (10.02M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (18.36M) (12.27M) (7.44M) (14.06M) (10.02M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (18.36M) (12.27M) (7.44M) (14.06M) (10.02M)
EPS (Basic) (1.90) (1.00) (0.58) (1.09) (0.77)
Basic Shares Outstanding 9.71M 12.67M 12.92M 12.94M 12.95M
EPS (Diluted) (1.90) (1.00) (0.58) (1.09) (0.77)
Diluted Shares Outstanding 9.71M 12.67M 12.92M 12.94M 12.95M
EBITDA (16.95M) (12M) (7.25M) (13.86M) (10.12M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.